Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Eur J Pharmacol ; 339(2-3): 161-4, 1997 Nov 27.
Article in English | MEDLINE | ID: mdl-9473131

ABSTRACT

Ventricular hypertrophy alters transporters associated with digitalis action, but the outcome of digitalis treatment on intracellular cations in the hypertrophied human myocardium remains unknown. Using double-barreled Ca2+-selective microelectrodes, we simultaneously measured Ca2+ activity and membrane potential in myocardial samples from patients without and with ventricular hypertrophy, prior to and following exposure to strophanthidin, a prototype digitalis. We found that ventricular hypertrophy is associated with greater strophanthidin-induced increase in diastolic Ca2+ levels compared to that observed in the absence of hypertrophy. Furthermore, in hypertrophied myocardium the magnitude of the increase in Ca2+ induced by strophanthidin was inversely related to increase in myocardial mass. Thus, the extent of ventricular hypertrophy determines digitalis action on intracellular Ca2+ within the human myocardium.


Subject(s)
Calcium/metabolism , Hypertrophy, Left Ventricular/drug therapy , Myocardium/metabolism , Strophanthidin/therapeutic use , Adult , Aged , Digitalis , Humans , Hypertrophy, Left Ventricular/metabolism , Middle Aged , Plants, Medicinal , Plants, Toxic
SELECTION OF CITATIONS
SEARCH DETAIL